In animal models, EECP could upregulate the expression of vascular eNOS and downregulate the activity of extracellular signal-regulated kinase 1/2 (ERK1/2) and inhibit the development of intimal hyperplasia and atherosclerosis (23). The gene discussed is MAPK3; the disease is atherosclerosis.